Opportunities in the North America molecular diagnostics market include rising demand due to increased chronic and infectious diseases, advances in point-of-care testing, and next-generation ...

Allied Market Research published a report, titled, "Genomics Market by Product (Consumables and Reagent, Services, Instruments and Systems and Software), Technology (Sequencing, PCR, Flow Cytometry, ...

For a century and a half, the sharp end of a needle has been the price of admission for modern medicine. Generations of ...

Comprehensive residue-level mapping of amyloid-beta recognition reveals how sequence variants, post-translational ...

In a warming corner of Iceland, tiny soil microbes are quietly rewriting one of Earth’s most fundamental life-support systems ...

The parents of a Derbyshire toddler who is one of 15 people across the world with a rare genetic condition have made a plea ...

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...

Mir195 enables Ebf1-deficient hematopoietic progenitor cells to mature into B cells, suggesting some miRNA can substitute for transcription factors in differentiation.

For the quarter ended December 2025, Illumina (ILMN) reported revenue of $1.16 billion, up 5% over the same period last year. EPS came in at $1.35, compared to $0.86 in the year-ago quarter. The ...

According to Mordor Intelligence, the proteomics market size was valued at USD 29.92 billion in 2025 and projected to grow ...

Beyond analysts' top-and-bottom-line estimates for Illumina (ILMN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...